Conditional approvals: is fast always better?
- At: 2009 FIP Congress in Istanbul (Turkey)
- Type: Presentation
- By: LEUFKENS, Hubert (UU, UIPS, Pharmacoepidemiology & Pharmacotherapy, Utrecht, Netherlands)
Hubert G. Leufkens, Utrecht Institute for Pharmaceutical Sciences (UIPS) and the Dutch Medicines Evaluation Board (MEB), The Netherlands Since the various regulatory systems have been implemented in the early 60s of the last century to guarantee the benefit-risk (B/R) of medicinal products, there has been a lively debate about what the best.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.